Patients with functional cardiac disturbances, including chest pain, may present electrocardiographic abnormalities (pronounced RS-T depressions and T-wave inversions) after the "2-step" exercise test which are indistinguishable from those found in organic heart disease. Ergotamine tartrate was employed intravenously in conjunction with "2-step" tests in 10 cases for the objective differentiation of functional from organic heart involvement. However, ergotamine was found to be contraindicated as a routine for this purpose because of its anginal-provoking properties. We have substituted dihydroergecornine (DHO-180), a newer, safer ergot alkaloid, in our further investigation of this problem.
T HE DISTINCTION between organic heart disease and functional heart disturbance is a very practical one. The usual means of investigation are not sufficient for this differentiation. Thus a physical examination, teleroentgenogram of the chest, fluoroscopy of the heart, and electrocardiogram which yield normal findings do not rule out the possibility of occlusive disease of the coronary arteries. In approximately 25 per cent of patients with coronary artery disease the results of these examinations are entirely normal.' Our personal experience has led us to believe that a typical history of angina pectoris, relieved by nitroglycerin, may occur even in patients with functional heart pain.
The "2-step" exercise electrocardiogram and the 10 per cent oxygen test are being used with increasing frequency for the diagnosis of coronary artery disease when all other findings are normal, particularly those of the resting electrocardiogram.2' 3 Unfortunately, in a very emotionally unstable person, electrocardiographic abnormalities may appear even in such an objective examination as the "2-step" exercise electrocardiogram or the 10 per cent oxygen test. In other words, if the disturbance From the Cardiographic Department of the Mount Sinai Hospitil, New York, N. Y. 692 is functional, the electrocardiogram may be altered and altered in the same degree as it is in a patient with severe anginal syndrome due to coronary artery disease. Patients who are under severe mental or emotional tension and those suffering from anxiety neurosis or from severe neurocirculatory asthenia may have a positive "2-step" electrocardiogram.4 The effect of emotion on the heart and on the electrocardiogram has been emphasized by a number of authors. 5 6 Nordenfelt7 used ergotamine tartrate parenterally for differentiating functional from organic alterations in the electrocardiogram. Wendkos and Logue8 used the drug in the differentiation of "sympathicogenic distortions of the T waves" from those due to organic heart disease. Bidrek9 reported the reversal of the electrocardiogram to normal during hypoxemia tests performed after the injection of 0.5 mg. of ergotamine tartrate in 9 of 10 patients with functional heart disturbances.
METHOD AND RESULTS
Since the effect of ergotamine on the "2-step" electrocardiogram has not been investigated, we decided to study the action of this drug administered intravenously to 5 patients with definite occlusive disease of the coronary MASTER, PORDY, KOLKER, AND BLUMENTHAL69 arteries and to 5 patients in whom there was undoubted functional heart disturbance without any evidence of organic disease. In all 10 cases the "2-step" exercise electrocardiogram was abnormal.
Ergotamine is one of many pharmacologically active alkaloids derived from the fungus Claviceps purpurea and is available commercially pulse rate of 20 to 30 beats per minute was cmoalong, with a rise in blood pressure of 20 to 40 mm. of mercury in both systolic and diastolic levels. Increase in amplitude of T waves was observed in the majority of subjects following the ergotamine injection ( fig. 1 ). This 26, 1948) showed no abnormality, but immediately after the standard "2-step" exercise, RS-T depressions appeared in Leads V4 and II. Ergotamine tartrate, 0.3 mg., was injected intravenously one hour later. The "2-step" exercise was repeated in fifteen minutes but no abnormal changes were noted in the electrocardiogram. as the tartrate salt in a 0.1 per cent solution (Gynergen-Sandoz-N.N.R.). * Ergotamine tartrate was administered intravenously in 0.3to 0.5-mg. doses. After intravenous injection in all 10 patients the effects of ergotamine became marked in from fifteen to thirty minutes and lasted up to one hour or more. A drop in * The Gynergen for this study was kindly supplied by the Sandoz Company, New York. exercise electrocardiogram made following the administration of the druig.
We chose 5 patients with functional heart disturbance (table 1) in whom physical examination, teleroentgenogram of the chest, and fluoroscopy of the heart demonstrated no abnormality. The electrocardiogram, consisting of the three standard limb leads, the augmented unipolar extremity leads (aVR, aVL, and aVF), and the unipolar precordial , + , t X s $ r < > < 1 i i i (table 1, Cases 3 and 5) gave typical histories of angina pectoris and both obtained slight but variable relief from nitroglycerin.
The "2-step" exercise electrocardiogram showed positive changes in all 5 patients and the electrocardiogram made during the 10 per cent oxygen (anoxemia) test demonstrated positive changes in four of these patients. However, when the ergotamine tartrate (0.3 trated by Case 2, in table 1, which refers to a woman physician 30 years of age with anxiety neurosis and a one-year history of atypical angina pectoris. Physical examination showed no essential abnormality. A control electrocardiogram was normal, but immediately after the standard "2-step" exercise the pattern was abnormal with RS-T depressions in Leads V4 and II. Ergotamine tartrate (0.3 mg.) was MIASTE1R, PORDY, KOLKER, AND BUIAMENTHAL( injected intravenously one hour later. After fifteen minutes, bradycardia and heightening of the T waves were noted; the "2-step" exercise was repeated, but no abnormal changes in the electrocardiogram occurred ( fig. 1) .
The 5 patients with organic heart disease (table 2) all revealed a typical anginal syndrome, with pain or pressure appearing after effort. Three of the patients were women and 2 were men. Their ages ranged from 44 to 76 years. Two of them had suffered coronary occlusions and four had hypertension. The resting electrocardiogram was abnormal in 2 (Cases 6 and 10, table 2). Ele(trocardiograms made during spontaneous attacks showed abnormality in all of these patients When opportunity for making these tracings during the episode of chest pain presented itself. Nitroglycerin brought relief to all.
In the group of patients with organic heart disease the "2-step" exercise electrocardiogram showed positive changes following the standard exertion, but in every instance when this was repeated after intravenous injection of ergotamine the electrocardiogram again showed abnormal patterns consisting of RS-T depressions and T-wave inversion. This is illustrated b)v Case 10, table 2, which refers to a woman 44 years of age with a history of acute posteriorwall mvocardial infarction one year previously and a four-month history of typical angina pectoris and marked dyspnea. Her blood pressure was 180/105. The control electrocardiogram was abnormal with left-axis deviation and a QT pattern in Leads II and III. Immediately after the standard "2-step" exercise, distinct RS-T depressions in Leads V4, I, and II appeared. Two weeks later, ergotamine tartrate, 0.5 mg., was injected intra-'venously and after forty-five minutes a repeat "2-step" exercise test showed abnormal electrocardiographic findings similar to those of the control exercise test (fig. 2 ).
The anoxemia test (10 per cent oxygen) was performed in all the 5 patients with functional heart disturbance and was positive in 4. The anoxemia test was positive in 2 of the 3 patients with organic heart disease in whom this procedture w'as essaye(d.
COMME NT
The observation of electrocardiographic abnormalities such as RS-T segment depressions and T-wave inversions, which occur spontan-eously8 10 or during the hypoxemia test,9 has been made several times in emotionally unstable individuals without organic heart disease. Certain authors have used ergotamine tartrate to prevent such changes.7' 8 We have also observed RS-T depressions and Twave inversions following a standard "2-step" exercise test in such patients and have likewise prevented their appearance by means of ergotamine tartrate.
Some moot issues arise in the understanding of these facts. The exact mechanism of alteration of the electrocardiogram in the RS-T and T-wave segments of patients with functional disorders is unresolved. Lability of the autonomic nervous system has been thought by several investigators to be causally related to the electrocardiographic deviations in such patients.7110 The resemblance of the RS-T and T-wave patterns to those of coronary insufficiency suggests that reduced coronary blood flow may be responsible even in the patients with functional heart disturbances. Mainzer and Kraus5 believe that psychic impulses acting through the autonomic nervous system cause coronary vasoconstriction with resultant myocardial anoxemia and RS-T and T-wx'ave changes. Direct evidence for this is lacking in man. The present state of knowledge concerning the effect of the sympathetic and parasympathetic nerves on human coronary circulation does not permit a final answer. Recent animal workll 12 casts considerable doubt on the vasodilator actions of the sympathetic impulses on the coronary arteries.
Another mechanism which has been suggested to explain the electrocardiographic changes in functional heart disturbances is autonomic nervous system effect on cardiac action potentials by directly influencing cellular metabolism or membrane properties.8 Scherf andl Schlachman'3 state that direct sympathetic effects on the repolarization) process occur. Various investigators have used drugs which act on the autonomic nervous svstem to abolish 6, 97 TWO-STEP EXERCIS Isi EI, '2CTItO('A1l{DIOGRAMI electrocardiographic abnormalities in functional cases.7' 8 It seems that these electrocardiographic changes are closely related to the function of the autonomic, especially the sympathetic, nervous system. Although for years many investigators have been interested in this problem the precise influence in the electrocardiogram is not known.14-16
How ergotamine acts to prevent the RS-T depressions and T-wave inversions is another moot issue. In animals, experimental doses (0.1 mg. to 0.5 mg. per kilogram of body weight) possess strong sympatholytic and adrenolytic properties.'7' 18 In man, clinical dosage of 0.5 mg. produces effects not readily explained. There is evidence that it does produce some sympatholytic effects in clinical doses.19' 20 Its direct vasoconstrictor action on the arterial tree, however, masks many of the sympatholytic properties. The precise result of injection of a clinical dose depends on the size of the dose and the tonus of the sympathetic system at the time of injection. These two factors Icetermine the vasoconstricting action of ergotamine and a host of reflex changes which integrate the heart and peripheral vascular tree.'9
Although we had previously assumed4 that ergotamine tartrate prevented the electrocardiographic changes which followed exercise by sympatholysis, we now are of the opinion that this is problematic. If ergotamine were sympatholytic, according to the older concepts of coronary innervation it should favor coronary constriction, and would hardly tend to relieve the reduced coronary flow which has been postulated as a possible cause of the RS-T and T-wave deviations. Likewise the direct vasoconstrictor effect of ergotamine on the coronary circulation and the rise in blood pressure which increases the work of the heart both militate against the latter explanation. Obviously, the known effects of ergotamine which would tend to reduce the effective coronary blood flow are inadequate to explain its action in these functional cases unless one introduces another and independent effect on cardiac action potentials which can compensate, in healthy hearts, for all the factors tending to favor relative invo-cardial anoxemia. Its chronotropic effects (pulse slowing) suggest either a vagotonic action, sympathicolysis, a direct effect on the sinoauricular node, or a combination of these.
Amidst all these theoretic uncertainties, the results of the experiment are quite definite. Consistent differences in the electrocardiogram made following the "2-step" exercise test and after the injection of ergotamine there shown by patients with functional heart disturbances and those wvith organic heart disease. In the former the electrocardiogram remained unchanged while in the latter it still became abnormal after exercise. Sinus tachycardia, itself, may be associated with RS-T segment (lepressions anId must be excluded as a possible cause of such depressions following the exercise test. Examination of figure 1, illustrative of a functional case, reveals that a physiologic tachycardia occurs on exercise before and after administration of ergotamine tartrate whereas RS-T depressions are present before but are absent after the administration of the drug. (Each complex in the illustrations represents a complete cardiac cycle from P wave to l' wave.) Hence tachycardia per se is not responsible for the RS-T segment depressions in this case, nor in our other functional cases.
It must be emphasized that ergotamine tartrate, despite its apparent usefulness, is not recommended for the differential diagnosis of such cases because of its widely known ability'7 to precipitate anginal seizures in true organic heart disease; this occurred in 2 of the 3 patients with organic heart disease (table 2, Cases 7 and 9). In addition nausea and vomiting were frequent side reactions.
Further studies on the relationship of the vegetative nervous system and the electrocardiogram with the newer autonomic drugs may elucidate some of the problems raised in this discussion, and provide accurate, safe, clinical methods for distinguishing functional from organic heart disease. In view of the potential dangers associated with the use of ergotamine tartrate clinically, we are continuing our investigations using new, safer agents. Dihydroergocornine (DH0-180) shows promise in this field. 698 MAST7ER, PORDY, KOLKER, AND BLUMENTHAL69 SUMMARY 1. Individuals with severe neurotic complaints may exhibit electrocardiographic changes, following the "2-step" standard exercise test, indistinguishable from those of organic heart disease.
2. The "2-step" exercise tolerance test was performed in 10 patients with signs and symptoms referable to the heart both before an(l after the intravenous administration of ergotamine tartrate. In the 5 patients with functional disturbances the "2-step" test was positive before ergotamine administration but negfative following it. In the 5 patients known to he affected with organic coronary artery disease, the "2-step" test was positive both before and after the ergotamine injection.
3. In psychoneurotic subjects, electrocardiographic aberrations may occur in the "2-step" exercise electrocardiogram; the exact mechanism of this is not known. The changes may be related to altered coronary blood flow, or to a direct effect of the autonomic nervous system on the electrical potentials of the heart or on cardiac metabolism. 4. Ergotamine, which prevents these funetional electrocardiographic abnormalities, exerts its action in a manner ais yet unknown. The side reactions to ergotamine tartrate given intravenously were nausea, 'Vomiting, and also angina pectoris in 2 patients with coronary artery disease. The use of ergotamine is not recommended for differential diagnosis because of its angina-provoking properties in patients with definite coronary artery disease. Safer agfents (dihydroergocornine-DHO 180) are being investigated with encouraging reault.
